Emerging Markets Such As China and India Offer High Growth Opportunities for Major Players in the Bone Growth Stimulators Market

According to the new market research report Bone Growth Stimulator Market by Product (Device, Bone morphogenetic protein, PRP), Application (spinal fusion, Delayed Union & Non Union Bone Fracture, Dental, Maxillofacial), End User (Hospitals, Homecare, Academia, CROs) — Global Forecast , published by MarketsandMarkets™, The Bone Growth Stimulator Market is expected to reach USD 1.41 billion, at a CAGR of 5.4%.

Download PDF Brochure:


On the basis of application, the global bone growth stimulator market is segmented into spinal fusion surgeries, delayed union and nonunion bone fractures, oral and maxillofacial surgeries, and other applications. The spinal fusion surgeries segment accounted for the largest share of the market.

Browse and in-depth TOC on “Bone Growth Stimulator Market”

66 — Tables

67 — Figures

153 — Pages

On the basis of the end user, the global bone growth stimulator market is segmented into hospitals & clinics, home care, and academic & research institutes and CROs. The hospitals & clinics segment is expected to grow at the highest CAGR during the forecast period. The advantage of bone growth stimulation products over their counterparts is the key factor driving their adoption in this end-user segment.

On the basis of region, this bone growth stimulator market is classified into North America, Europe, Asia-Pacific, and the Rest of the World.

Read a Press-Release on “Bone Growth Stimulator Market”:


The Asia-Pacific market is expected to grow at the highest CAGR. This is primarily due to the presence of a large patient population for target diseases (coupled with rapidly growing geriatric population, especially in Japan and China), raising awareness among healthcare professionals related to novel and upcoming treatment options, and ongoing government initiatives to modernize & expand healthcare infrastructure.

Orthofix International N.V. (U.S.), DJO Finance LLC (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Bioventus LLC (U.S.), Medtronic plc (Ireland), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), and Harvest Technologies Corporation (U.S.) are some of the key players in the bone growth stimulator market.